This test has the potential ability to detect early cancers and precancerous polyps with greater accuracy." Dr Alexandre Akoulitchev, OBD's Chief Scientific Officer added: "Reliable and non ...

Depending on the type of polyps, they can be benign, be a sign of inflammation, or potentially lead to cancer. Polyps are abnormal tissue growths. Most people with gallbladder polyps do not ...

Health screenings, like those for colorectal cancer, can uncover issues at an early stage—when they may be more treatable. But as we get older, it’s not always clear which tests are still essential.

People with first-degree relatives who were repeatedly diagnosed with colorectal polyps appeared at increased risk for ...

Results of multi-institutional clinical study published in peer reviewed journal ‘Cancers’ confirms efficacy of Oxford BioDynamics’ EpiSwitch® blood-based Colorectal No-Stool Test (NST) Discussions ...

Results of multi-institutional clinical study published in peer reviewed journal 'Cancers' confirms efficacy ofOxford BioDynamics' EpiSwitch blood-based Colorectal No-Stool Test (NST) High ...

OXFORD, England, February 05, 2025--(BUSINESS WIRE)--Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D ...

The risk for colorectal cancer was associated with the frequency of colorectal polyp diagnoses in relatives in a study based ...

Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform, announces the publication of compelling ...